Teleflex study shows Arrowg+ard-protected central venous catheters cut CLABSI hazard 70% vs. plain lines
TFX•A newly published study linked Teleflex’s Arrowg+ard-protected central venous catheters to a 70% lower CLABSI hazard than plain lines and lower mortality, despite longer catheter use.
1. Study findings
The peer-reviewed study was published in the American Journal of Infection Control. It linked Arrowg+ard-protected catheters to fewer bloodstream infections than standard catheters and indicated lower mortality among patients using the impregnated catheters, despite longer time on the line.
